1Q26: DMD Study Initiation Now In 3Q Due To Regulatory Delays

Research evidence excerpt

1Q26: DMD Study Initiation Now In 3Q Due To Regulatory Delays

Equity Research

HEALTHCARE TECH, MEDIA & ENTERTAINMENT

Biotechnology Enterprise Software & Disruptive Technology

David Nierengarten, Ph.D. (415) 274-6862 david.nierengarten@wedbush.com Dan Ives (212) 344-2073 dan.ives@wedbush.com

Robert Driscoll, Ph.D. (415) 274-6863 robert.driscoll@wedbush.com Steven Wahrhaftig (212) 931-7059 steven.wahrhaftig@wedbush.com

Laura Chico, Ph.D. (212) 668-9868 laura.chico@wedbush.com Sam Brandeis (213) 223-3005 sam.brandeis@wedbush.com

Biotechnology Hardware/Semiconductors

Yun Zhong, Ph.D. (212) 738-7409 yun.zhong@wedbush.com Matt Bryson (617) 695-6302 matthew.bryson@wedbush.com

Biotechnology Hardware/Quantum Computing

Martin Fan (213) 688-3404 martin.fan@wedbush.com Antoine Legault (626) 497-1619 antoine.legault@wedbush.com

Internet

SPECIAL SITUATIONS Ygal Arounian (929) 259-1728 ygal.arounian@wedbush.com

Generalist Media & Entertainment

Michael Piccolo (212) 668-9863 michael.piccolo@wedbush.com Alicia Reese (212) 938-9927 alicia.reese@wedbush.com

Media & Entertainment

Matt McCartney (212) 738-7402 matt.mccartney@wedbush.com

Financial Institutions

Specialty Finance

Henry Coffey, CFA (212) 833-1382 henry.coffey@wedbush.com

RESEARCH MANAGEMENT

Seth Basham, CFA Kirsten Fraunces

Director of Research EVP, CAO

seth.basham@wedbush.com kirsten.fraunces@wedbush.com

(212) 938-9954 (213) 688-4404

COMMODITIES & AGRICULTURE

Al Kluis

Kluis Commodity Advisors

info@kluiscommodityadvisors.com

(888) 345-2855

FIXED INCOME FUTURES & RATES

Arthur Bass

Managing Director

Arthur.Bass@Wedbush.com

(212) 259-6582

CORPORATE ACCESS

Avishai Kantor Sophia Dao

Vice President, Corporate Access AVP, Corporate Access

Avishai.Kantor@wedbush.com Sophia.Dao@wedbush.com

(212) 259-6589 (213) 688-4380

TRADING